VEQUIOR Trademark
Trademark Overview
On Thursday, February 6, 2003, a trademark application was filed for VEQUIOR with the United States Patent and Trademark Office. The USPTO has given the VEQUIOR trademark a serial number of 78211784. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, June 24, 2005. This trademark is owned by Pfizer Inc.. The VEQUIOR trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations and ophthalmological preparations
General Information
| Serial Number | 78211784 |
| Word Mark | VEQUIOR |
| Filing Date | Thursday, February 6, 2003 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Friday, June 24, 2005 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 30, 2003 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations and ophthalmological preparations |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 4, 2003 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Pfizer Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10017 |
| Party Name | Pfizer Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10017 |
Trademark Events
| Event Date | Event Description |
| Wednesday, October 5, 2005 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Tuesday, September 27, 2005 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, January 4, 2005 | EXTENSION 2 GRANTED |
| Monday, December 20, 2004 | EXTENSION 2 FILED |
| Monday, December 20, 2004 | TEAS EXTENSION RECEIVED |
| Monday, December 20, 2004 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, June 8, 2004 | EXTENSION 1 GRANTED |
| Wednesday, June 2, 2004 | EXTENSION 1 FILED |
| Wednesday, June 2, 2004 | TEAS EXTENSION RECEIVED |
| Tuesday, December 23, 2003 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, September 30, 2003 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 10, 2003 | NOTICE OF PUBLICATION |
| Friday, August 8, 2003 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sunday, August 3, 2003 | ASSIGNED TO EXAMINER |
